CNFinance Holdings Limited filed a Form 6-K with the SEC on November 13, 2026, disclosing a change in its independent registered public accounting firm, effective that same date.
Navios Maritime Partners L.P. filed a Form 6-K on November 13, 2026, attaching its Notice of 2026 Annual Meeting of Limited Partners and Proxy Statement for a meeting scheduled for December 18, 2026, in Piraeus, Greece.
Jason Conley, EVP and Chief Financial Officer of Roper Technologies Inc., filed a Form 4 on November 13, 2026, disclosing a disposition of 1,000 shares of common stock on November 12, 2026.
Director Noel Bertram Watson of Affirm Holdings, Inc. filed a Form 4 on November 13, 2026, disclosing the sale of 2,000 shares of Class A Common Stock on November 10, 2026, under a pre-established Rule 10b5-1 trading plan.
ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Form 4 with the SEC on November 13, 2026, disclosing a purchase of 12,333 shares of NextCure, Inc. common stock on November 11, 2026.
Julie K. Sperber, VP and Chief Accounting Officer of MGIC Investment Corp, filed a Form 4 on November 13, 2026, disclosing the sale of 8,265 shares of common stock on November 12, 2026.
Robert Wayne Prejean, Chief Executive Officer and Director of Drilling Tools International Corp, filed a Form 4 on November 13, 2026, disclosing an open-market purchase of common stock on November 12, 2026.
Director Jack D. Furst filed a Form 4 with the SEC on November 13, 2026, disclosing a purchase of 1,750 shares of Drilling Tools International Corp common stock on November 12, 2026.
Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), filed a Form 4 on November 13, 2026, disclosing an option exercise and same-day sale of 8,874 shares of common stock on November 11, 2026, pursuant to a Rule 10b5-1 plan.
Director Eric C. Neuman filed a Form 4 with the SEC on November 13, 2026, disclosing a purchase of common stock in Drilling Tools International Corp on November 12, 2026.